The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Goldberg Y. Paul since year 2005.
The trader's CIK number is 1619960.
At the time of this reporting, Goldberg Y. Paul is the VP of Clinical Development of Xenon Pharmaceuticals Inc. .
(stock ticker symbol XENE).
See this page for all insider trading activities at Xenon Pharmaceuticals Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2015-09-24||XENE||Xenon Pharmaceuticals Inc.||Sale||12,000||8.60||103,200|
|2015-09-23||XENE||Xenon Pharmaceuticals Inc.||Sale||4,000||9.02||36,080|
|2015-09-22||XENE||Xenon Pharmaceuticals Inc.||Sale||6,149||9.33||57,382|
|2015-09-22||XENE||Xenon Pharmaceuticals Inc.||Option Ex||30,388||3.49||106,145|
|2015-08-18||XENE||Xenon Pharmaceuticals Inc.||Option Ex||3,085||4.90||15,101|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goldberg Y. Paul (VP of Clinical Development of Xenon Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.